210 related articles for article (PubMed ID: 11359765)
1. Src homology 2 domain-containing inositol 5-phosphatase 1 mediates cell cycle arrest by FcgammaRIIB.
Malbec O; Schmitt C; Bruhns P; Krystal G; Fridman WH; Daëron M
J Biol Chem; 2001 Aug; 276(32):30381-91. PubMed ID: 11359765
[TBL] [Abstract][Full Text] [Related]
2. Negative regulation of mast cell proliferation by FcgammaRIIB.
Malbec O; Attal JP; Fridman WH; Daëron M
Mol Immunol; 2002 Sep; 38(16-18):1295-9. PubMed ID: 12217398
[TBL] [Abstract][Full Text] [Related]
3. Negative regulation of c-kit-mediated cell proliferation by Fc gamma RIIB.
Malbec O; Fridman WH; Daëron M
J Immunol; 1999 Apr; 162(8):4424-9. PubMed ID: 10201978
[TBL] [Abstract][Full Text] [Related]
4. A mouse Fcgamma-Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases.
Mertsching E; Bafetti L; Hess H; Perper S; Giza K; Allen LC; Negrou E; Hathaway K; Hopp J; Chung J; Perret D; Shields M; Saxon A; Kehry MR
J Allergy Clin Immunol; 2008 Feb; 121(2):441-447.e5. PubMed ID: 17949802
[TBL] [Abstract][Full Text] [Related]
5. Two distinct tyrosine-based motifs enable the inhibitory receptor FcgammaRIIB to cooperatively recruit the inositol phosphatases SHIP1/2 and the adapters Grb2/Grap.
Isnardi I; Lesourne R; Bruhns P; Fridman WH; Cambier JC; Daëron M
J Biol Chem; 2004 Dec; 279(50):51931-8. PubMed ID: 15456754
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of the recruitment of the SH2 domain-containing inositol 5-phosphatases SHIP1 and SHIP2 by fcgamma RIIB.
Bruhns P; Vely F; Malbec O; Fridman WH; Vivier E; Daeron M
J Biol Chem; 2000 Dec; 275(48):37357-64. PubMed ID: 11016922
[TBL] [Abstract][Full Text] [Related]
7. The SH2 domain containing inositol 5-phosphatase SHIP2 associates to the immunoreceptor tyrosine-based inhibition motif of Fc gammaRIIB in B cells under negative signaling.
Muraille E; Bruhns P; Pesesse X; Daëron M; Erneux C
Immunol Lett; 2000 Apr; 72(1):7-15. PubMed ID: 10789675
[TBL] [Abstract][Full Text] [Related]
8. The SH2 domain-containing inositol 5-phosphatase SHIP1 is recruited to the intracytoplasmic domain of human FcgammaRIIB and is mandatory for negative regulation of B cell activation.
Isnardi I; Bruhns P; Bismuth G; Fridman WH; Daëron M
Immunol Lett; 2006 Apr; 104(1-2):156-65. PubMed ID: 16406061
[TBL] [Abstract][Full Text] [Related]
9. Fc epsilon receptor I-associated lyn-dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation.
Malbec O; Fong DC; Turner M; Tybulewicz VL; Cambier JC; Fridman WH; Daëron M
J Immunol; 1998 Feb; 160(4):1647-58. PubMed ID: 9469421
[TBL] [Abstract][Full Text] [Related]
10. The effect of phosphatases SHP-1 and SHIP-1 on signaling by the ITIM- and ITAM-containing Fcgamma receptors FcgammaRIIB and FcgammaRIIA.
Huang ZY; Hunter S; Kim MK; Indik ZK; Schreiber AD
J Leukoc Biol; 2003 Jun; 73(6):823-9. PubMed ID: 12773515
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis reveals multiple distinct sites within Fc gamma receptor IIB that function in inhibitory signaling.
Fong DC; Brauweiler A; Minskoff SA; Bruhns P; Tamir I; Mellman I; Daeron M; Cambier JC
J Immunol; 2000 Oct; 165(8):4453-62. PubMed ID: 11035084
[TBL] [Abstract][Full Text] [Related]
12. A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.
Wisniewski D; Strife A; Swendeman S; Erdjument-Bromage H; Geromanos S; Kavanaugh WM; Tempst P; Clarkson B
Blood; 1999 Apr; 93(8):2707-20. PubMed ID: 10194451
[TBL] [Abstract][Full Text] [Related]
13. Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism.
An H; Xu H; Zhang M; Zhou J; Feng T; Qian C; Qi R; Cao X
Blood; 2005 Jun; 105(12):4685-92. PubMed ID: 15701712
[TBL] [Abstract][Full Text] [Related]
14. Dynamic interactions of Fc gamma receptor IIB with filamin-bound SHIP1 amplify filamentous actin-dependent negative regulation of Fc epsilon receptor I signaling.
Lesourne R; Fridman WH; Daëron M
J Immunol; 2005 Feb; 174(3):1365-73. PubMed ID: 15661894
[TBL] [Abstract][Full Text] [Related]
15. IgG-Independent Co-aggregation of FcεRI and FcγRIIB Results in LYN- and SHIP1-Dependent Tyrosine Phosphorylation of FcγRIIB in Murine Bone Marrow-Derived Mast Cells.
Gast M; Preisinger C; Nimmerjahn F; Huber M
Front Immunol; 2018; 9():1937. PubMed ID: 30210494
[TBL] [Abstract][Full Text] [Related]
16. FcgammaRIIB-mediated inhibition of T-cell receptor signal transduction involves the phosphorylation of SH2-containing inositol 5-phosphatase (SHIP), dephosphorylation of the linker of activated T-cells (LAT) and inhibition of calcium mobilization.
Jensen WA; Marschner S; Ott VL; Cambier JC
Biochem Soc Trans; 2001 Nov; 29(Pt 6):840-6. PubMed ID: 11709085
[TBL] [Abstract][Full Text] [Related]
17. Downstream of kinase, p62(dok), is a mediator of Fc gamma IIB inhibition of Fc epsilon RI signaling.
Ott VL; Tamir I; Niki M; Pandolfi PP; Cambier JC
J Immunol; 2002 May; 168(9):4430-9. PubMed ID: 11970986
[TBL] [Abstract][Full Text] [Related]
18. Co-clustering of Fcgamma and B cell receptors induces dephosphorylation of the Grb2-associated binder 1 docking protein.
Koncz G; Tóth GK; Bökönyi G; Kéri G; Pecht I; Medgyesi D; Gergely J; Sármay G
Eur J Biochem; 2001 Jul; 268(14):3898-906. PubMed ID: 11453982
[TBL] [Abstract][Full Text] [Related]
19. The SH2 inositol 5-phosphatase Ship1 is recruited in an SH2-dependent manner to the erythropoietin receptor.
Mason JM; Beattie BK; Liu Q; Dumont DJ; Barber DL
J Biol Chem; 2000 Feb; 275(6):4398-406. PubMed ID: 10660611
[TBL] [Abstract][Full Text] [Related]
20. Protein-tyrosine phosphatase SHP-1 is dispensable for FcgammaRIIB-mediated inhibition of B cell antigen receptor activation.
Nadler MJ; Chen B; Anderson JS; Wortis HH; Neel BG
J Biol Chem; 1997 Aug; 272(32):20038-43. PubMed ID: 9242674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]